Skip to content

Dose finding study of stellate ganglion in precision medicine.

Dose finding study of stellate ganglion in precision medicine.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102229
Enrollment
Unknown
Registered
2025-05-12
Start date
2025-05-16
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morning stiffness

Interventions

Intervention group:Drug volumes for each patient were randomly formulated according to biased coin design.

Sponsors

Zhejiang Provincial Tongde Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Patients who visited the pain department of our hospital due to morning palm stiffness and needed SGB treatment; 2.Age 18-60 years old; 3.They agreed to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Taking drugs affecting coagulation function or abnormal coagulation function; 2.Severe systemic diseases, such as cardiovascular and cerebrovascular diseases, respiratory diseases, liver and kidney diseases, etc. 3.Eye diseases; 4.There were problems affecting the operation such as infection or deformity at the puncture site. 5.History of allergy to lidocaine, ultrasound coupler, and iodophor. 6.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Horner's syndrome;Local anesthetic volume of first visit;

Secondary

MeasureTime frame
The onset time of SGB;Complications;Local anesthetic volume of return visit;

Countries

China

Contacts

Public ContactBingwei Hu

Zhejiang Provincial Tongde Hospital

whoboy555@139.com+86 571 89972308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026